Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Sunshine: BIO co-signs letter to HHS Secretary Kathleen Sebelius

Oct 25 2011

...

Sunshine Letter to HHS Secretary Kathleen Sebelius

Oct 25 2011
BIO signs on to letter to HHS Secretary Kathleen Sebelius, regarding the Physician Payments Sunshine Provision.

PDUFA V: BIO Supports Timely Reauthorization of PDUFA to Promote the Development of Innovative Therapies and Speed New Medicines to Patients

Oct 24 2011

...

BIO Comments on the CARB on the Harmonization Chapter

Oct 21 2011
BIO comments on the draft “Harmonization” chapter (the chapter) of CARB report.

BIO Comments on the CARB on the Harmonization Chapter

Oct 21 2011
BIO comments on the draft “Harmonization” chapter (the chapter) of CARB report.

Paraguay IP Section 306 Monitoring: BIO Comments

Oct 20 2011
BIO urges the United States Trade Representative to continue to address the persistent deficiencies in patent protection and data protection regimes in Paraguay.  These deficiencies raise issues in respect to Paraguay's bilateral and international obligations and deny adequate and effective protection for the intellectual property rights of BIO's members.

NADAC: BIO's Comments on the Survey of Retail Prices

Oct 20 2011

...

Mobile Medical Applications: BIO Comments

Oct 19 2011

...

Therasense USPTO Implementation: BIO Comments on the Revision of the Standard for the Duty to Disclose

Oct 19 2011
BIO believes the Therasense decision marks an important positive step in the evolution of the inequitable conduct doctrine, and appreciates and applauds its quick embrace by the USPTO.  BIO believes that the decision, in conjunction with the Leahy-Smith America Invents Act of 2011, offers opportunities to re-think and restructure administrative applicant disclosure obligations in ways that go beyond what would be possible under the USPTO’s proposed revised Rule alone.  

Companion Diagnostics: BIO Comments on FDA Draft Guidance

Oct 14 2011

...